EGFR and adenocarcinoma: Specifically, while EGFR mutations occur in approximately 15% of adenocarcinoma NSCLC in Caucasian populations in Canada, USA and Europe, this mutation is far more frequent in the East Asian population, with a prevalence of 40–50% (reviewed in [19]).